top of page
AdobeStock_725041655_edited.jpg

Weight Loss

Fuel your goals, ignite your potential.
These once weekly injections help:

  • Regulate blood sugar levels

  • Reduce cravings

  • Slow the emptying of the stomach

  • Control your glucose production

  • Decrease your risk of cardiovascular disease & diabetes

  • Reduce blood pressure

  • Ease joint pain

  • Substantial A1C reductions

Tirzepatide

Tirzepatide contributes to weight loss through multiple mechanisms linked to its dual hormone action. Firstly, by mimicking GLP-1 (glucagon-like peptide-1), it enhances feelings of fullness and satiety, leading to reduced appetite and lower calorie intake. Secondly, as a GIP (glucose-dependent insulinotropic polypeptide) agonist, it possibly enhances the body’s energy expenditure. Tirzepatide also slows down gastric emptying, which prolongs the feeling of fullness after meals. These combined effects help individuals reduce their food intake and potentially increase calorie burning, contributing to significant weight loss, as observed in clinical studies. This makes tirzepatide an effective treatment option for managing both type 2 diabetes and obesity.

Recent studies have shown that patients lose an average of 20.9% of their body weight using Tirzepatide. With some noticeable weight loss in the first month, the full benefits are evident after 3–6 months of treatment.

Get started by filling out the contact form below!

Semaglutide

Semaglutide is a medication used for the treatment of type 2 diabetes and, more recently, for weight management in adults. It belongs to a class of drugs known as GLP-1 receptor agonists, which mimic the action of the naturally occurring hormone GLP-1, enhancing insulin secretion and suppressing glucagon secretion. Semaglutide promotes weight loss primarily through its action on appetite regulation centers in the brain. As a GLP-1 receptor agonist, it mimics the effects of the naturally occurring hormone glucagon-like peptide-1 (GLP-1), which plays a role in appetite and food intake. By activating GLP-1 receptors in the brain, semaglutide increases feelings of fullness and satiety while reducing hunger. This leads to a decrease in overall calorie intake, supporting weight loss. Additionally, semaglutide may slow gastric emptying, further contributing to increased feelings of fullness after eating. These effects combined help individuals reduce their food intake and manage their weight more effectively.

Recent studies have shown an average weight loss of 14.9% of a patient’s initial body weight when using Semaglutide. With some noticeable weight loss in the first month, the full benefits are evident after 3-6 months of treatment.

bottom of page